Showing results (1191-1200 of 1,351) with videos related to
Sort By:
Pageof 136
Communications Medicine|September 10, 2024
Prospective multicenter study using artificial intelligence to improve dermoscopic melanoma diagnosis in patient careLukas Heinlein, Roman C Maron, Achim Hekler, et al.European Journal of Cancer (Oxford, England : 1990)|May 15, 2022
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022Claus Garbe, Teresa Amaral, Ketty Peris, et al.Nature Communications|July 2, 2026
Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 yearsClaus Garbe, Ulrike Keim, Teresa Amaral, et al.Journal for Immunotherapy of Cancer|June 20, 2020
Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosingDanny Rischin, Michael R Migden, Annette M Lim, et al.The Lancet. Oncology|October 24, 2023
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 studyNeil D Gross, David M Miller, Nikhil I Khushalani, et al.Journal for Immunotherapy of Cancer|March 12, 2024
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinomaDanny Rischin, Brett G M Hughes, Nicole Basset-Séguin, et al.Neurobiology of Aging|February 9, 2024
Vascular risk burden is a key player in the early progression of Alzheimer's diseaseJoão Pedro Ferrari-Souza, Wagner S Brum, Lucas A Hauschild, et al.European Journal of Cancer (Oxford, England : 1990)|June 22, 2022
Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline - Update 2022Marie-Léa Gauci, Cynthia Aristei, Jurgen C Becker, et al.European Journal of Cancer (Oxford, England : 1990)|December 25, 2024
An update on access to novel treatment for metastatic melanoma in Europe - A 2024 survey of the European melanoma registry and the European association of dermato-oncologyL Kandolf, P A Ascierto, L Bastholt, et al.European Journal of Cancer (Oxford, England : 1990)|January 26, 2024
Efficacy and safety of 'Second Adjuvant' therapy with BRAF/MEK inhibitors after local therapy for recurrent melanoma following adjuvant PD-1 based immunotherapyAmelia M Taylor, Janet McKeown, Florentia Dimitriou, et al.Pageof 136